Department of Biological Sciences and Bioengineering, Center for Environmental Sciences and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, UP, India; Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund 221 85, Sweden.
Department of Orthopedics, Clinical Sciences Lund, Lund University, Lund 221 85, Sweden; Department of Biomedical Engineering, Lund University, Lund 221 00, Sweden.
J Control Release. 2016 Aug 10;235:365-378. doi: 10.1016/j.jconrel.2016.05.061. Epub 2016 May 29.
Osteoinduction can be enhanced by combining scaffolds with bone morphogenic protein-2 (BMP-2). However, BMP's are known to also cause bone resorption. This can be controlled using bisphosphonates like zoledronic acid (ZA). In this study, we produced two different scaffolds containing silk-fibroin, chitosan, agarose and hydroxyapatite (HA) with and without bioactive glass. The aims of the study were to fabricate, physico-chemically characterize and evaluate the carrier properties of the scaffolds for recombinant human BMP-2 (rhBMP-2) and ZA. Scaffolds were characterized using various methods to confirm their composition. During cell-material interactions, both scaffolds exhibited gradual but sustained proliferation of both C2C12 and MSCs for a period of 6weeks with augmentative effects on their phenotype indicated by elevated levels of alkaline phosphatase (ALP) cuing towards osteogenic differentiation. In-vitro effects of rhBMP-2 and ZA contained within both the scaffolds was assessed on MC3T3 preosteoblast cells and the results show a significant increase in the ALP activity of the cells seeded on scaffolds with rhBMP-2. Further, the scaffold with both HA and bioactive glass was considered for the animal study. In-vitro, this scaffold released nearly 25% rhBMP-2 in 21-days and the addition of ZA did not affect the release. In the animal study, the scaffolds were combined with rhBMP-2 and ZA, rhBMP-2 or implanted alone in an ectopic muscle pouch model. Significantly higher bone formation was observed in the scaffold loaded with both rhBMP-2 and ZA as seen from micro-computed tomography, histomorphometry and energy dispersive X-ray spectroscopy.
骨诱导作用可以通过将支架与骨形态发生蛋白-2(BMP-2)结合来增强。然而,已知 BMP 也会引起骨吸收。这可以通过使用唑来膦酸(ZA)等双膦酸盐来控制。在这项研究中,我们制备了两种不同的支架,其中含有丝素蛋白、壳聚糖、琼脂糖和羟基磷灰石(HA),并添加了和未添加生物活性玻璃。研究的目的是制造、物理化学表征和评估支架对重组人 BMP-2(rhBMP-2)和 ZA 的载体性能。通过各种方法对支架进行了表征,以确认其组成。在细胞与材料相互作用过程中,两种支架均表现出 C2C12 和 MSC 的逐渐但持续的增殖,其表型呈扩增趋势,碱性磷酸酶(ALP)水平升高,提示向成骨分化。还评估了 rhBMP-2 和 ZA 对 MC3T3 前成骨细胞的体外作用,结果表明,在载有 rhBMP-2 的支架上接种的细胞的 ALP 活性显著增加。此外,还考虑了具有 HA 和生物活性玻璃的支架进行动物研究。在体外,该支架在 21 天内释放了近 25%的 rhBMP-2,添加 ZA 不会影响释放。在动物研究中,将支架与 rhBMP-2 和 ZA、rhBMP-2 或单独植入异位肌肉囊中模型。从微计算机断层扫描、组织形态计量学和能量色散 X 射线光谱分析中可以看出,在负载 rhBMP-2 和 ZA 的支架中观察到更高的骨形成。